- HOME
- NIKKEI Drug Discovery Ecosystem Summit
NIKKEI Drug Discovery Ecosystem Summit
Nikkei Inc. will hold the “NIKKEI Drug Discovery Ecosystem Summit” on June 24 and 25, 2025. The summit will identify the institutional, financial, human resource development, and R&D challenges that Japan faces today in order to build a drug discovery ecosystem that will lead to enhance drug discovery capabilities, and invite a wide range of stakeholders in drug discovery, including industry, government, academia, and the private sector. The content of the discussions will be widely disseminated to the public through the Summit, leading to the revitalization of drug-discovery innovation in Japan.
All those who are interested in innovation, regardless of the pharmaceutical industry, are cordially invited to attend.
概要OVERVIEW
- Date
- June 24 (Tue.) - June 25 (Wed), 2025
【Day1】9:00～18:30
【Day2】9:00～17:00
- Venue
- Capacity
【In-person】300 people
【Online】 No limit
- Participation fee
Free
- Organizer
Nikkei Inc.
- Special cooperation
Japan Pharmaceutical Manufacturers Association (JPMA)
- Sponsors
Astellas Pharma Inc.
CHUGAI PHARMACEUTICAL CO., LTD.
Gilead Sciences, Inc.
Novartis Pharma K.K.
Shinsei Capital Partners, Ltd.
Takeda Pharmaceutical Company Limited
- Supporters
Cabinet Office
Ministry of Economy, Trade and Industry
- Registration deadline
【In-person】 June 19 (Thu.) , 2025
【Online】 June 25 (Wed.) , 2025 17:00
- Contact
NIKKEI Drug Discovery Ecosystem Summit Secretariat
Program
【Day1】 June 24 (Tuesday)
9:00～9:05 Greeting from the organizer
9:05～9:10 Video Message
9:10～9:30 Keynote Speech
9:30～10:50 Panel Session 1
Kenichiro Watanabe, Director, National Healthcare Policy Secretariat, Cabinet Office
Rami Suzuki, Representative Director CEO, ARC Therapies Inc.
Shinichiro Fuse, TPG Life Sciences Innovations, Partner/Managing Director
＜Moderator＞
Akihiko Soyama, CEO, Life Science Innovation Network Japan / Specially Appointed Professor, Tohoku University
10:50～11:00 Break
11:00～11:50 Special Session 1
11:50～13:30 Panel Session 2
Tadayoshi Mizutani,Director, Policy Planning Division for Pharmaceutical Industry Promotion and Medical Information Management, Health Policy Bureau, Ministry of Health, Labour and Welfare
Hitoshi Kuboniwa, Japan Bioindustry Association,Chairman Steering Committee
Yukiko Nishimura, NPO ASrid, President
Yasuhiro Fujiwara, Chief Executive, Pharmaceuticals and Medical Devices Agency
＜Moderator＞
Shintaro Sengoku, Professor, School of Environment and Society, Institute of Science Tokyo
13:30～13:40 Break
13:40～15:00 Panel Session 3
Hirokazu Shimoda, Director, Policy Planning Division for Pharmaceutical Industry Promotion and Medical Information Management, Health Policy Bureau, Ministry of Health, Labour and Welfare
Yoshiki Sawa, President,Organization of Future Medicine
Toshio Fujimoto, Chief Executive Officer iPark Institute Co., Ltd.
Yusaku Katada, Restore Vision Inc. CEO
Morten Sogaard, Head, Innovation Lab, Astellas Pharma
＜Moderator＞
Masamitsu Harata, Chairman, CEO and Founder at Human Life CORD Japan Inc.
15:00～15:50 Special Session 2
15:50～16:00 Special Speech 1
16:00～16:50 Special Session 3
16:50～17:00 Break
17:00～18:30
NIKKEI Drug Discovery Startup Pitch
Finalist Presentation DAY1
【Day2】 Wednesday, June 25
9:00～9:20 Special Speech 2
9:20～10:40 Panel Session 4
Kanae Kurata, Director, Life Sciences Division, Research Promotion Bureau, Ministry of Education, Culture, Sports, Science and Technology (MEXT)
Shin Kaneko, Professor, Center for iPS Cell and Research Application, Kyoto University
Professor, Faculty of Medicine, University of Tsukuba
Kaneshiro Kiyohumi, Chief Financial Officer, PeptiDream Inc.
Takeyuki Akiyama, Director, Japan Alliance for Lysosomal Disease Patient Organizations
Shinichiro Komoto, Eight Roads Ventures Japan・Partner
Fumi Kubota, Editor in Chief, Nikkei Buiotechnology & Business, Nikkei Business Publications, Inc.
10:40～11:30 Special Session 4
11:30～11:40 Break
11:40～12:10 Special Speech 3
12:10～13:30 Panel Session 5
Yasushi Okuno, Professor, Department of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University
Hiroyuki Tsunoda, Deputy Head of Research Division, Chugai Pharmaceutical Co., Ltd.
13:30～13:40 Break
13:40～15:10 Panel Session 6
Shintaro Sengoku, Professor, School of Environment and Society, Institute of Science Tokyo
Asuka Miyabashira, President of Japan Pharmaceutical Manufacturers Association
Hitoshi Nakagama, Japan Agency for Medical Research and Development/President
＜Moderator＞
Kiyoshi ANDO, Senior Staff Writer, Nikkei Inc.
15:10～15:20 Break
15:20～16:50
NIKKEI Drug Discovery Startup Pitch
Finalist Presentation DAY2
